HomeDAWN • NASDAQ
Day One Biopharmaceuticals Inc
add
$7.21
3.15%
After Hours:(0.00%)0.00
$7.21
Closed: Sep 18, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 33.91M | 313.92% |
Operating expense | 65.12M | -46.75% |
Net income | -30.32M | -588.04% |
Net profit margin | -89.42 | -66.21% |
Earnings per share | -0.29 | -480.00% |
EBITDA | -34.09M | 70.23% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 453.10M | 25.21% |
Total assets | 519.04M | 29.62% |
Total liabilities | 58.20M | -37.89% |
Total equity | 460.83M | — |
Shares outstanding | 102.43M | — |
Price to book | 1.55 | — |
Return on assets | -16.60% | — |
Return on capital | -18.48% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -30.32M | -588.04% |
Cash from operations | -24.81M | 49.51% |
Cash from investing | 26.32M | 54.32% |
Cash from financing | 748.00K | -42.33% |
Net change in cash | 2.26M | 107.36% |
Free cash flow | -12.44M | 49.56% |
Previous close
$6.99
Day range
$7.05 - $7.21
Year range
$5.64 - $16.75
Market cap
738.53M USD
Avg Volume
1.51M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
182